Cargando…
Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling
Postsurgical recurrence within 2 years is the major cause of poor survival of hepatocellular carcinoma (HCC) patients. However, the molecular mechanism underlying HCC recurrence remains unclear. Here, we distinguish the function and mechanism of Sec62 in promoting HCC recurrence. The correlation bet...
Autores principales: | Du, Juan, Zhao, Zhihao, Zhao, Hetong, Liu, Dong, Liu, Hui, Chen, Jun, Cheng, Binbin, Zhai, Xiaofeng, Yin, Zifei, Zhang, Yani, Ling, Changquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904485/ https://www.ncbi.nlm.nih.gov/pubmed/31822656 http://dx.doi.org/10.1038/s41389-019-0183-6 |
Ejemplares similares
-
Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection
por: Weng, Li, et al.
Publicado: (2012) -
Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma
por: Zhao, Hetong, et al.
Publicado: (2017) -
m(6)A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2021) -
Stepwise gating of the Sec61 protein-conducting channel by Sec63 and Sec62
por: Itskanov, Samuel, et al.
Publicado: (2021) -
The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors
por: Zimmermann, Julia S. M., et al.
Publicado: (2022)